# Radiation Therapy, Combination Chemotherapy, and Amifostine in Treating Patients With Head and Neck Cancer

> **NCT00003582** · PHASE1,PHASE2 · COMPLETED · sponsor: **University of Miami** · enrollment: 36 (estimated)

## Conditions studied

- Carcinoma of Unknown Primary
- Head and Neck Cancer

## Interventions

- **DRUG:** amifostine trihydrate
- **DRUG:** cisplatin
- **DRUG:** fluorouracil
- **DRUG:** paclitaxel
- **PROCEDURE:** quality-of-life assessment
- **RADIATION:** radiation therapy

## Key facts

- **NCT ID:** NCT00003582
- **Lead sponsor:** University of Miami
- **Sponsor class:** OTHER
- **Phase:** PHASE1,PHASE2
- **Study type:** INTERVENTIONAL
- **Status:** COMPLETED
- **Start date:** 1988-05
- **Primary completion:** 1996-12
- **Final completion:** 1996-12
- **Target enrollment:** 36 (ESTIMATED)
- **Last updated:** 2016-12-15


## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT00003582

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT00003582, "Radiation Therapy, Combination Chemotherapy, and Amifostine in Treating Patients With Head and Neck Cancer". Retrieved via AI Analytics 2026-05-28 from https://api.ai-analytics.org/clinical/NCT00003582. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*